Why biosimilars are much harder than generics

In today's episode of The Daily Brief, we cover two major stories shaping the Indian economy and global markets:

00:04   Intro
00:27   The race to replicate Keytruda
13:21   How CBAM hits Indian steel
22:22   Tidbits

We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll make you smart every day: https://thedailybriefing.substack.com/

Note: This content is for informational purposes only. None of the stocks, brands, or products mentioned are recommendations or endorsements.